Comment from Consumer Healthcare Products Association (CHPA)

Summary: The Consumer Healthcare Products Association (CHPA) opposes the citizen petition requesting new neurodevelopmental warning language for OTC acetaminophen products. They argue that the petition fails to provide credible evidence of a causal link between postnatal acetaminophen use and autism or other neurodevelopmental outcomes, citing existing scientific literature and regulatory standards.